June 2, 2017 10:58 AM EDT
Peer Review

Eli Lil­ly's CFO re­tir­ing af­ter 27 years at com­pa­ny; Alex­ion names a new slate of ex­ecs

Emma Yasinski

→ Mi­na Sooch has re­signed as pres­i­dent, CEO, and di­rec­tor of Gem­phire, cit­ing “per­son­al rea­sons.” The com­pa­ny has strug­gled fi­nan­cial­ly and its drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times